Raymond James & Associates’s Gain Therapeutics GANX Stock Holding History

Raymond James & Associates’s Portfolio GANX Stock Details GANX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$980K	Buy
2023 Q4	$77.7K	Sell
2023 Q3	$111K	Buy
2023 Q2	$150K	Buy
2023 Q1	$96.4K	Sell
2022 Q4	$75.1K	Hold
2022 Q3	$78K	Buy